The US Food and Drug Administration approvedAbbott’s Aveir dual chamber (DR) leadless pacemaker system.
About 80% of people who need a pacemaker to treat bradycardia or another abnormal heart rhythm will need dual-chamber...
Cardio Catch-Up: Abbott Plans To Expand Pacemaker Market With Leadless Aveir DR
The FDA approved Abbott’s Aveir DR dual-chamber leadless pacemaker system, which will complement Abbott’s Aveir VR technology and help Abbott compete directly with Medtronic in the growing leadless cardiac rhythm management device market.
More from Approvals
• By
Clairity’s "first-in-class" mammography-based AI screening tool, Clairity Breast, provides "equitable risk assessments," expanding access to lifesaving early detection for breast cancer, said company founder Connie Lehman.
• By
Abbott received the US FDA nod for its Tendyne system, offering a minimally invasive alternative to replace the valves of patients with severe mitral valve disease who are at risk for open-heart surgery.
• By
The US FDA has approved the Teal Wand, the first at-home cervical cancer screening device. Capable of detecting preclinical cancer with 96% accuracy, it will launch in California in June and expand nationwide soon after.
• By
NeuroOne is preparing to submit its OneRF Trigeminal Nerve Ablation System to the US FDA for treating trigeminal neuralgia, a chronic facial pain condition. CEO Dave Rosa told Medtech Insight that he expects a possible product launch by fall 2025.
More from Policy & Regulation
• By
Preparations for the reauthorization of the Medical Device User Fee Amendments for 2028-2032 are underway, with the US FDA announcing a public meeting for 4 August. After negotiations with industry and other stakeholders, a draft agreement is due to Congress by 15 January 2025.
• By
Robert Foster, HHS deputy general counsel and chief counsel for food, research and drugs, is temporarily heading the Office of Chief Counsel, but a permanent appointee is expected after Michael Stuart's confirmation as HHS general counsel.
• By
The US FDA recently published a draft guidance document for manufacturers of mesh products that are used during several types of hernia repair procedures.